Psilocybin and Anorexia Research: Why Metabolism and Exercise May Shape Psychedelic Effects
Psilocybin — the naturally occurring compound found in magic mushrooms — has been gaining attention as a potential treatment for a wide range of mental health conditions. One area researchers are beginning to explore more closely is its possible role in treating anorexia nervosa, a complex and often difficult-to-treat eating disorder.
Early clinical trials have shown that many patients experience improvements after psychedelic therapy. However, results haven’t been consistent across the board. Now, new preclinical research suggests these differences may not be random at all. Instead, they could be influenced by factors like metabolic state and exercise history — essentially, what’s happening in the body as well as the brain.
A nesen veikts pētījums from Monash University, published in Genomic Press Psychedelics, sheds new light on how psilocybin affects social behavior and immune signaling in female mice, and why context matters more than previously thought.
Why Researchers Are Studying Psilocybin for Anorexia
Nervozā anoreksija is one of the most serious psychiatric disorders, with high relapse rates and limited effective treatment options. Beyond severe weight loss, people with anorexia often experience social withdrawal, difficulty processing emotions, and increased inflammation in the body.
Interestingly, many of these symptoms overlap with depression and anxiety, both of which are linked to changes in serotonin signaling. This is the same brain system psilocybin primarily interacts with.
Psilocybin has already shown promise in treating mood disorders, and human studies have associated psychedelic therapy with reduced inflammation several days after treatment. These findings have sparked growing interest in whether the compound could also help address eating disorders.
Another important factor is that most psychedelic research has historically been conducted on male animals, even though anorexia is far more common in females. This new study helps fill that gap by focusing specifically on female mice.
How Scientists Modeled Anorexia in the Lab
To better understand how psilocybin might work in different physiological states, researchers used a well-established model called activity-based anorexia.
In this setup, mice have limited access to food while also having access to a running wheel. This combination typically leads to rapid weight loss, increased activity, and anxiety-like behaviors. These patterns resemble key aspects of anorexia nervosa.
The mice were divided into four groups:
- Activity-based anorexia (food restriction plus exercise)
- Food restriction only
- Exercise only with unlimited food
- Standard control group
Once the anorexia group reached 75 to 85 percent of their starting body weight, researchers administered a moderate dose of psilocybin.
A few hours later, the mice took part in behavioral tests designed to measure social preference and interest in novelty. Blood samples were also collected to measure interleukin-6, an inflammatory marker linked to psychiatric and metabolic disorders.
This design allowed researchers to examine how food restriction, exercise, and their combination influenced psilocybin’s effects.
Surprising Changes in Social Behavior
One of the most unexpected findings was how the mice behaved socially.
The activity-based anorexia group did not become less social, as researchers initially expected. Instead, they showed a stronger preference for interacting with unfamiliar mice, indicating increased interest in social novelty.
Mice that exercised but had unlimited food also showed greater interest in social novelty, although this appeared later during testing. Meanwhile, mice that were only food-restricted did not show the same pattern.
Psilocybin itself did not increase sociability overall. In the control group, the drug actually reduced interest in social novelty. This lead mice to spend similar amounts of time with familiar and unfamiliar mice.
Among food-restricted mice, those with lower body weight paid more attention to a new object than to another mouse, suggesting their motivation was more focused on finding food.
These findings suggest that starvation and physical activity can significantly shape social motivation. Increased novelty-seeking might help animals locate food during times of scarcity, but it could also reflect compulsive patterns similar to those seen in anorexia and addiction.
The Role of Exercise in Immune Response
The researchers also examined inflammation by measuring interleukin-6 levels.
At baseline, levels were similar across all groups, which differs from human studies that often find higher inflammation in people with anorexia. However, psilocybin changed this pattern in one specific group: mice that exercised but were not food-restricted.
These mice showed higher interleukin-6 levels after treatment compared to other groups. Interestingly, higher inflammation in this group was linked to greater interest in social novelty.
This relationship did not appear in food-restricted mice, suggesting that prior starvation may disrupt the connection between psilocybin, inflammation, and behavior.
The findings indicate that exercise may alter how psilocybin influences immune signaling, possibly through metabolic pathways related to reward and motivation. Timing may also play a role, since human studies typically observe anti-inflammatory effects days after treatment rather than just hours later.
Why Context Matters for Psychedelic Therapies
Taken together, the study highlights an important takeaway: the effects of psychedelics are not fixed. They can vary depending on what’s happening in the body, not just the brain.
A treatment that reduces social novelty in one context may have little effect — or even the opposite effect — in another. This variability has major implications for clinical research and future therapies.
People with different exercise habits, metabolic states, or illness histories may respond differently to the same psychedelic treatment. In the future, biomarkers related to inflammation or activity levels could help predict who is most likely to benefit.
What This Means for the Future of Research
The findings underscore the need for more nuanced research into psychedelic therapies. Future studies will need to track behavioral and immune changes over longer timeframes and compare responses between males and females.
For now, the research reinforces a growing understanding that psilocybin’s effects emerge from complex interactions between the brain, body, and environment, rather than being determined by the compound alone.
A Broader Perspective on Psychedelics and the Body
As psychedelic science continues to evolve, studies like this remind us that these compounds don’t operate in isolation. Nutrition, physical activity, inflammation, and overall health may all shape how experiences unfold and how therapeutic benefits emerge.
Understanding these interactions could help researchers design more personalized approaches to treatment. This could also deepen our understanding of how mind and body work together in altered states.
While much more research is needed before psilocybin could become a standard treatment for eating disorders, this study marks another step toward understanding the complex biology behind psychedelic effects — and why context truly matters.
